These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12425211)

  • 1. [Acetylsalicylic acid (ASA)--is everything clear?].
    Spinar J; Vítovec J
    Vnitr Lek; 2002 Aug; 48(8):781-90. PubMed ID: 12425211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial.
    Latini R; Santoro E; Masson S; Tavazzi L; Maggioni AP; Franzosi MG; Barlera S; Calvillo L; Salio M; Staszewsky L; Labarta V; Tognoni G;
    Heart Dis; 2000; 2(3):185-90. PubMed ID: 11728260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
    Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M
    Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
    Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
    Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of assessment of aggregation of thrombocytes induced by cationic propyl gallate to estimate recurrence of cardiovascular complications].
    Stejskal D; Prosková J; Lacnák B; Horalík D; Hamplová A; Oral I; Hrabovská I; Ochmanová R; Adamovská S; Juráková R; Ozanová G; Juchelka J; Kulísková O; Pĕnkavová H
    Vnitr Lek; 2004 Aug; 50(8):591-9. PubMed ID: 15521202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.
    Bauriedel G; Skowasch D; Schneider M; Andrié R; Jabs A; Lüderitz B
    Am Heart J; 2003 Feb; 145(2):343-8. PubMed ID: 12595854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aspirin, angiotensin converting enzyme inhibitors and cardiac insufficiency].
    de Groote P; Aumégeat V; Meurice T; Millaire A; Lamblin N; Lablanche JM
    Arch Mal Coeur Vaiss; 2000 Feb; 93(2):167-71. PubMed ID: 10830093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
    Feringa HH; Bax JJ; Karagiannis SE; Noordzij P; van Domburg R; Klein J; Poldermans D
    Arch Gerontol Geriatr; 2009; 48(1):116-20. PubMed ID: 18177954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Which interactions are there for equal doses of acetylsalicylic acid and ACE inhibitors?].
    Joost HG
    Dtsch Med Wochenschr; 2003 Feb; 128(8):398. PubMed ID: 12594628
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acetylsalicylic acid and ACE inhibitors in heart disease--a phenomenon in dogs and cats?].
    Bĕlohlávek J; Aschermann M
    Vnitr Lek; 2002 Aug; 48(8):695-7. PubMed ID: 12425197
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of suspected cardiac ischemia with aspirin by paramedics in an urban emergency medical services system.
    McVaney KE; Macht M; Colwell CB; Pons PT
    Prehosp Emerg Care; 2005; 9(3):282-4. PubMed ID: 16147476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The degree of inflammation and endothelial dysfunction in treatment of chronic heart failure in patients with coronary artery disease].
    Sazhina EIu; Kozlova IV; Rebrov AP; Al'tshuler MIu
    Klin Med (Mosk); 2006; 84(12):20-4. PubMed ID: 17294877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trials.
    Frazier CG; Shah SH; Armstrong PW; Bhapkar MV; McGuire DK; Sadowski Z; Kristinsson A; Aylward PE; Klein WW; Weaver WD; Newby LK;
    Am Heart J; 2005 Dec; 150(6):1260-7. PubMed ID: 16338269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin use in chronic heart failure: what should we recommend to the practitioner?
    Massie BM
    J Am Coll Cardiol; 2005 Sep; 46(6):963-6. PubMed ID: 16168276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
    Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
    Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studies.
    Hirsh J; Bhatt DL
    Arch Intern Med; 2004 Oct; 164(19):2106-10. PubMed ID: 15505123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving rationale for angiotensin-converting enzyme inhibition in chronic heart failure.
    Banerjee A; Talreja A; Sonnenblick EH; LeJemtel TH
    Mt Sinai J Med; 2003 Sep; 70(4):225-31. PubMed ID: 12968195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.